AIM
PMD

Acrospire Investment Management’s Psychemedics Corporation PMD Stock Holding History

Acrospire Investment Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,612
Closed -$65K – 1515
2017
Q2 		$65K Sell
2,612
-1,848
-41% -$38.8K 0.06% 606
2017
Q1 		$89K Sell
4,460
-3,066
-41% -$67.3K 0.07% 398
2016
Q4 		$186K Buy
7,526
+6,342
+536% +$142K 0.08% 413
2016
Q3 		$23K Buy
+1,184
New +$22K 0.02% 1454

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Acrospire Investment Management's PMD Position: Q3 2017 in Review

Acrospire Investment Management sold out of Psychemedics Corporation (PMD) in Q3 2017, closing a stake of 2,612 shares — an estimated $65K sold.

Acrospire Investment Management first reported a position in PMD in Q3 2016 and held it in 4 quarters. The position peaked at $186K in Q4 2016. 51 funds tracked by Wall St. Rank hold PMD as of Q3 2017.

  • Acrospire Investment Management reported no remaining Psychemedics Corporation position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,612 Psychemedics Corporation shares in Q3 2017, an estimated $65K.
  • Acrospire Investment Management first reported a position in Psychemedics Corporation in Q3 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Psychemedics Corporation position peaked at $186K in Q4 2016.
  • 51 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.